Alnylam shareholders re-elect four Class II directors, approve say-on-pay and auditor

ALNYLAM PHARMACEUTICALS, INC.

All four Class II nominees (Ausiello, Brandicourt, Kellogg, Pyott) re-elected with >90% of votes cast.
Non-binding advisory vote on executive compensation passed: 106.8M for, 6.1M against.
Ratification of PricewaterhouseCoopers as FY2024 auditor approved: 114.5M for, 3.5M against.
All proposals passed with substantial margins; total shares outstanding 126,452,099.
Terms of eight other directors continued after the meeting; no changes to board composition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.